I made no reference to TGA in my post so I am not too sure why you have launched into these details.
I merely wanted to clear it up for everyone on this forum that the UK post market Trial DID NOT achieve it's primary endpoints which was to measure the level of SARS-CoV-2 viral load in the nose of all patients over a 7-day treatment period compared with placebo as well as in other relevant subpopulations.
CASE CLOSED.
I made no reference to TGA in my post so I am not too sure why...
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.31M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.9¢ | $14.97K | 151.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 372123 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 5042 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |